ArticleJournal for immunotherapy of cancer2022

Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer.

Brie Chun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.